Rosal, Adelfa C.

HRN: 27-58-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 500MG (TAB)
08/06/2025
08/06/2025
IV
1.5g
Once
Prior To OR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: